Pricing Log in Create free account

SpyGlass Pharma, Inc. (SGP) vs Verastem, Inc. (VSTM)

SpyGlass Pharma, Inc. and Verastem, Inc. are both Biotechnology companies. SpyGlass Pharma, Inc. and Verastem, Inc. are of similar size ($1.1B and $1.1B). SpyGlass Pharma, Inc. has the higher net margin (0.00% vs −178.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, SpyGlass Pharma, Inc. leads on 8 and Verastem, Inc. on 4.

Valuation

Metric SGP VSTM Biotechnology median
P/E n/m n/m 10.60
P/S n/m 8.51 9.40
P/B 5.24 84.49 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 7.98 9.02
Earnings yield (24.85%) (21.95%) (32.88%)
Free cash flow yield (3.81%) (18.70%) (23.13%)

Profitability

Metric SGP VSTM Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% (193.73%) 0.00%
Net margin 0.00% (178.38%) 0.00%
Free cash flow margin 0.00% (159.10%) 0.00%
Return on equity (51.34%) 6,595.50% (51.96%)
Return on assets (35.97%) (88.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SGP VSTM Biotechnology median
Revenue growth (TTM) — 286.13% 6.76%
EPS growth (last fiscal year) (10.25%) 17.49% 29.88%
Revenue growth, 5-year CAGR — 12.11% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric SGP VSTM Biotechnology median
Debt to equity 0.00 11.82 0.00
Current ratio 25.06 1.93 4.97
Net debt to EBITDA 2.63 0.76 1.01

Dividend

Metric SGP VSTM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SGP VSTM Biotechnology median
Market cap 1.14b 1.14b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack